Another disease model, in which IBD was induced in Sprague-Dawley rats by dextran sulfate sodium (DSS), demonstrated that the B2R antagonist FR173657 inhibited shortening of the colon, suggesting that KKS activation worsens colitis due to bradykinin-induced B2R signaling (21). Here, BDKRB2 is linked to colitis.